Skip to main content
. Author manuscript; available in PMC: 2018 Mar 25.
Published in final edited form as: Int J Med Inform. 2017 Oct 4;108:85–91. doi: 10.1016/j.ijmedinf.2017.10.003

Table 3.

Top cities, sites, and sponsors that recruited trial participants.

Condition Top Cities that Hosted Recruitments (Total Hosted
Facility Counts)
Most Frequently Used Sites in the City (Site
Frequency)
Top Sponsors (Sponsor Frequency)
Breast Cancer Boston, MA, US (783) Dana-Farber Cancer Institute (126) Dana-Farber Cancer Institute (60)
Beth Israel Deaconess Medical Center (95) National Cancer Institute (NCI) (39)
Massachusetts General Hospital (90) Massachusetts General Hospital (25)
New York, NY, US (767) Memorial Sloan Kettering Cancer Center (116) Memorial Sloan Kettering Cancer Center (145)
Columbia University Medical Center (38) National Cancer Institute (NCI) (34)
Mount Sinai Medical Center (28) New York University School of Medicine (23)
Seattle, WA, US (668) Fred Hutchinson Cancer Research Center (53) University of Washington (43)
Group Health Central Hospital (51) Southwest Oncology Group (24)
University Cancer Center at University of Washington Medical Center (48) NSABP Foundation Inc. (18)
Diabetes San Antonio, TX, US (928) Novo Nordisk Clinical Trial Center (96) AstraZeneca (75)
GSK Investigational Site (78) Novo Nordisk (59)
Local Research Site (55) Pfizer (39)
Dallas, TX, US (839) Novo Nordisk Clinical Trial Center (169) Novo Nordisk (72)
GSK Investigational Site (52) Eli Lilly and Company (44)
Local Research Site (35) AstraZeneca (41)
Miami, FL, US (776) Novo Nordisk Clinical Trial Center (101) Novo Nordisk (48)
GSK Investigational Site (38) AstraZeneca (45)
Local Research Site (33) Merck Sharp & Dohme Corp (40)
Malaria Bamako, Mali (47) Malaria Research and Training Center (17) National Institute of Allergy and Infectious Diseases (NIAID) (22)
University of Bamako (12) Pfizer (3)
Pfizer Investigational Site (4) University of California San Francisco (2)
Kisumu, Kenya (32) GSK Investigational Site (11) Centers for Disease Control and Prevention (6)
Kenya Medical Research Institute (5) GlaxoSmithKline (5)
CDC KEMRI Research Institute (2) Pfizer (2)
Ouagadougou, Burkina Faso (31) Centre National de Recherché et de Formation sur le Paludisme (7) GlaxoSmithKline (6)
GSK Investigational Site (5) London School of Hygiene and Tropical Medicine (5)
Pfizer Investigational Site (2) Gates Malaria Partnership (3)